Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
about
Bisphosphonates: from bench to bedsideHormone predictors of abnormal bone microarchitecture in women with anorexia nervosaBisphosphonates and bone quality.Effects of suppression of bone turnover on cortical and trabecular load sharing in the canine vertebral body.Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.High-resolution computed tomography for clinical imaging of bone microarchitecture.Differences between the bisphosphonates for the prevention and treatment of osteoporosis.Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone massAbnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosisExcessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strengthShear strength and toughness of trabecular bone are more sensitive to density than damageChanges in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.Discovery, clinical development, and therapeutic uses of bisphosphonates.Risedronate for prevention and treatment of osteoporosis in postmenopausal women.Structure Model Index Does Not Measure Rods and Plates in Trabecular Bone.A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover.Canadian Consensus Conference on osteoporosis, 2006 update.Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography.Effects of risedronate on fracture risk in postmenopausal women with osteopeniaAn approach to compare the quality of cancellous bone from the femoral necks of healthy and osteoporotic patients through compression testing and microcomputed tomography imaging.Bone quality: what is it and how is it measured?Human cancellous bone from T12-L1 vertebrae has unique microstructural and trabecular shear stress propertiesDetermination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats.Trabecular bone structure analysis in the limited spatial resolution regime of in vivo MRI.Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy.Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy.Current, new and future treatments of osteoporosis.Use of bisphosphonates in the management of postmenopausal osteoporosis.Trabecular architecture and vertebral fragility in osteoporosis.Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients.Using Osteoporosis Therapies in Combination.Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.Small-Diameter Awls Improve Articular Cartilage Repair After Microfracture Treatment in a Translational Animal Model.Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization-induced bone loss.Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis.Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study.Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18 months.Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
P2860
Q28251212-730BB21B-D911-4F7D-9468-B90F50E76144Q33636697-0DB08DE3-250D-414B-A2ED-03B7471AB2C3Q33683219-CC4764B7-4CFD-4BC4-8B81-D953D08EC983Q33923777-97C8F99A-5A98-4ECD-9F83-1F0B55E62C07Q34346425-68C65B25-7A89-49ED-BA2A-10AE15EE099EQ35078843-78E5DF32-3066-4815-A022-1B80E4E330CFQ35166767-3CF198C5-5CC0-4123-B72A-102B477F32B4Q35384673-870364A2-40A6-4326-851E-B0B562A29D35Q35432980-1D1740C4-9CB8-4F12-AF33-440016A9F6FDQ35442489-C7045FD4-C0E7-4E68-8E86-88706EA13B4DQ35529112-D65ED00C-392E-4E4B-91CF-FAAF0375E532Q35954529-5A8A0BC6-AB93-433E-AF13-9D884CE74CF8Q36065420-0F3AC4D2-409B-4812-864A-52C049C74A8EQ36082078-79BDA18E-1318-4277-93FB-3B4E8C3B770EQ36149699-2740F321-D85E-40C6-83C4-4C4DC0166071Q36177169-608787E2-7A35-44B8-85EE-CE66E9D2D47CQ36454421-58B2607A-2A13-441C-A177-CE7C165929F6Q36498921-48B1D4BA-8F49-406E-BA15-A82BE829D6E9Q36514462-0D7690A3-904F-415D-B9F0-CBAFE175A2DDQ36571235-33E80DE7-2A38-4F1B-8DD2-9C6EACD1DDBAQ36658905-23E4C394-9AB1-4482-80E0-20BB89191388Q37155618-1146167F-A93E-4396-A08C-ECE0B68FB486Q37255950-CB8F1AF2-4AD9-4436-BDAC-1F1255EB62F1Q37409512-1DE2C2BE-9C4B-4EF1-BACF-909A32260A3BQ37467472-D54BA287-9659-4791-9B7B-DC7C798C9B93Q37467475-BF831838-4BB7-4BEC-8B7C-A1D46F84EDBEQ37777053-06A8D389-18BA-4C50-8A69-69AE91357928Q37800181-16CB696B-FB7F-49C9-B03B-EB1EA58634BBQ38001598-764B6BE8-DF97-48C0-8682-29F7700163F3Q38138867-B4C40C34-5927-4828-9D5C-6864800B611EQ38599112-43617A9C-1E59-491C-9CD3-56B284757828Q39408210-446AB240-0A9C-4D11-A2BD-B3452979AFCBQ39569410-DBB350EB-DFAD-43BF-B766-50ACA3CA8B4AQ40346716-B2BB650E-2571-4963-AB9A-E8CFA7366967Q40372812-17299A03-D1A3-4037-96F2-F413EED7EF43Q42115678-B602925A-196A-42BD-BD90-9EFBB785B193Q44257423-A797C01B-1E76-44EB-BA1F-F1259EF20391Q44599521-4AEB8444-14BE-48C7-9852-F155152C2663Q46040516-60192BBD-258C-4DEE-988A-12D5F94F4441Q46907008-A4C74538-A97C-45D6-A007-A80ED7FA9A9B
P2860
Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Risedronate preserves bone arc ...... onal microcomputed tomography.
@en
Risedronate preserves bone arc ...... onal microcomputed tomography.
@nl
type
label
Risedronate preserves bone arc ...... onal microcomputed tomography.
@en
Risedronate preserves bone arc ...... onal microcomputed tomography.
@nl
prefLabel
Risedronate preserves bone arc ...... onal microcomputed tomography.
@en
Risedronate preserves bone arc ...... onal microcomputed tomography.
@nl
P2093
P1433
P1476
Risedronate preserves bone arc ...... onal microcomputed tomography.
@en
P2093
Arkadi Chines
Babul Borah
Michael D Manhart
Paula A Chmielewski
Thomas E Dufresne
Troy D Johnson
P304
P356
10.1016/J.BONE.2003.12.013
P577
2004-04-01T00:00:00Z